AC
RLYB icon

Almitas Capital’s Rallybio RLYB Stock Holding History

Almitas Capital’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.72M Sell
191,206
-1
-0% -$7 0.39% 50
2025
Q4 		$1.05M Sell
191,207
-1,134
-0.6% -$5.84K 0.23% 57
2025
Q3 		$768K Sell
192,341
-34,846
-15% -$146K 0.18% 51
2025
Q2 		$614K Buy
227,187
+64,614
+40% +$171K 0.16% 51
2025
Q1 		$851K Buy
162,573
+308
+0.2% +$1.95K 0.28% 50
2024
Q4 		$1.25M Buy
162,265
+52,836
+48% +$443K 0.27% 50
2024
Q3 		$1.02M Buy
109,429
+96,819
+768% +$933K 0.36% 45
2024
Q2 		$135K Buy
+12,610
New +$171K 0.06% 73

Other funds holding RLYB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Almitas Capital's RLYB Position: Q1 2026 in Review

Almitas Capital reduced its Rallybio (RLYB) stake by 0% in Q1 2026, selling an estimated $7 and leaving 191,206 shares worth $1.72M. The position accounts for 0.39% of the portfolio, ranked #50.

Almitas Capital first reported a position in RLYB in Q2 2024 and has held it in 8 quarters since. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • Almitas Capital held 191,206 shares of Rallybio worth $1.72M as of Q1 2026.
  • Almitas Capital sold 1 Rallybio share in Q1 2026, an estimated $7.
  • Rallybio made up 0.39% of Almitas Capital's portfolio in Q1 2026, its #50 holding.
  • Almitas Capital first reported a position in Rallybio in Q2 2024 and has held it in 8 quarters since.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on Almitas Capital's 13F filing for Q1 2026, filed 15 May 2026.